Company Valuation: MEDICLIN AG

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 186.2 171 130.2 115 175.8 188.1 - -
Change - -8.16% -23.89% -11.68% 52.89% 7.03% - -
Enterprise Value (EV) 186.2 171 130.2 115 175.8 188.1 188.1 188.1
Change - -8.16% -23.89% -11.68% 52.89% 7.03% 0% 0%
P/E - - - - - - - -
PBR 1.02x 0.82x 0.66x 0.52x 0.71x 0.66x 0.59x 0.52x
PEG - - - - - - - -
Capitalization / Revenue 0.28x 0.24x 0.18x 0.15x 0.22x 0.24x 0.23x 0.23x
EV / Revenue 0x 0x 0x 0x 0x 0.24x 0.23x 0.23x
EV / EBITDA 0x 0x 0x 0x 0x 1.65x 1.63x 1.63x
EV / EBIT 0x 0x 0x 0x 0x 3.03x 3.01x 3x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Dividend per Share 2 - - - - 0.04 0.04 0.04 0.04
Rate of return - - - - 1.08% 1.01% 1.01% 1.01%
EPS 2 - - - - - - - -
Distribution rate - - - - - - - -
Net sales 1 673.1 704.7 730.1 748.8 784.5 787.5 803.2 819.3
EBITDA 1 85.22 90.92 98.73 103.8 115.6 114.3 115.3 115.6
EBIT 1 11.56 19.52 12.72 53.49 55.36 62.11 62.47 62.72
Net income 1 1.461 9.441 -10.78 24.84 25.49 36.66 38.2 40.12
Net Debt - - - - - - - -
Reference price 2 3.920 3.600 2.740 2.420 3.700 3.960 3.960 3.960
Nbr of stocks (in thousands) 47,500 47,500 47,500 47,500 47,500 47,500 - -
Announcement Date 3/30/22 3/31/23 3/27/24 3/28/25 3/27/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
32.83x3.15x14.03x1.36% 18.46B
64.8x5.11x34.6x0.27% 13.1B
19.48x2.81x10.01x2.15% 10.93B
16.51x1.94x9.11x0.76% 10.05B
23.05x1.86x15.51x0.16% 9.45B
18.27x2.69x11x4.42% 9B
67.33x8.08x35.21x0.13% 7.64B
32.59x0.89x7.39x1.98% 6.84B
12.61x1.1x6.68x2.07% 6.81B
Average 31.94x 3.07x 15.95x 1.48% 10.25B
Weighted average by Cap. 32.93x 3.17x 16.51x 1.41%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield